Meeting Overview - The fifth meeting of the board of directors of Guangdong Marubi Biotechnology Co., Ltd. was held on August 21, 2025, with all 9 directors present [1] - The meeting was convened in compliance with relevant laws and regulations, and the resolutions passed are legally valid [1] Resolutions Passed - All resolutions were approved with 9 votes in favor, 0 against, and 0 abstentions [2][3] - The resolutions included the approval of the 2025 semi-annual report and the special report on the use of raised funds [2] Financial Decisions - The company and its subsidiaries are authorized to apply for a comprehensive credit limit of up to 1.2 billion RMB for various financing activities [3] - A cash dividend of 2.50 RMB (including tax) per 10 shares will be distributed to shareholders based on the total share capital on the record date [3] Upcoming Events - The company will hold its first extraordinary general meeting of 2025 to review the proposed resolutions [4]

Group 1 - The board of directors of Shandong Weifang Runfeng Chemical Co., Ltd. held its 28th meeting on August 20, 2025, to discuss and approve various resolutions [1][2] - The company confirmed that its 2025 semi-annual report accurately reflects its operational status without any false records or omissions [1][2] - The board approved a cash dividend of RMB 3.50 per 10 shares (including tax) to all shareholders, based on the total share capital minus repurchased shares [2][3] Group 2 - The board reviewed and confirmed that the management and use of raised funds comply with relevant regulations, ensuring no violations occurred [2][3] - The company revised its articles of association and governance-related systems in accordance with the latest legal requirements [3][4] - The board proposed the nomination of candidates for the fifth board of directors, with a term of three years pending shareholder approval [5][6]